Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Proteolytic Enzymes (Proteases) has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Adding a microbial protease alongside whey was tested for its effect on how much and how fast amino acids appeared in plasma after the meal. Whey is already rapidly digested, so the headroom for improvement is smaller than with slower proteins. Plasma amino acid appearance is a marker of digestion, not a measure of muscle gained.
Pancreatin carries trypsin and chymotrypsin, which cut at basic and aromatic residues respectively. Microbial and plant proteases cut at different points along the chain. Combining classes produces more complete breakdown of a protein than any single specificity does, which is why multi-enzyme blends are the formulation norm.
Bromelain from pineapple stem is a cysteine protease that stays active across a wide pH range, which is unusual and makes it useful both in the stomach and further down. It is normally one of several proteases in a blend rather than a standalone. Activity is declared in GDU or MCU units, not milligrams.
Papain from papaya latex is a broad-specificity cysteine protease that pairs with bromelain in most systemic enzyme formulations. The two have different optimal pH ranges, so together they cover more of the gut transit than either alone. Activity units, not weight, determine how much work either one does.
Pepsin is only active below about pH 4 and is irreversibly denatured as pH rises past 6. In people with low stomach acid the first stage of protein digestion is impaired regardless of how much pepsin is present. Betaine hydrochloride is used to lower gastric pH so pepsin can work, which is a different problem from adding more enzyme.
Pepsin cleaves dietary protein into large peptides in the stomach, and pancreatic and supplemental proteases then cut those peptides down further. Skipping the gastric phase leaves larger substrates for everything downstream. The two act in sequence rather than in parallel.
A meal contains protein, starch and fat, and each needs its own enzyme class. Protease handles only the protein fraction, so a broad formulation pairs it with amylase and lipase. This is standard formulation, not a discovered interaction.
Collagen peptides are manufactured by exposing collagen to proteases until the chains are short enough to dissolve and absorb. Taking additional protease with an already-hydrolysed product adds little, because the work has been done upstream. Worth knowing before paying for both.
Active proteases in the same capsule as other protein-based ingredients will act on them during storage and in the gut. Formulators separate the two into different beads or delayed-release layers for this reason. This is a manufacturing consideration rather than a physiological conflict.
The pancreatic carboxypeptidases that trim single amino acids from peptide chain ends require a zinc ion in the active site. Low zinc status impairs that final trimming step. This is a cofactor relationship, so it matters at deficiency and not above it.
In one trial added microbial protease raised postprandial plasma amino acid appearance after pea protein, while the whey trial measured the same endpoint without reporting a clear direction. Comparing across two separate trials is indirect, so read the idea that slower proteins leave more headroom as reasoning rather than a measured comparison. Casein clots in the stomach and empties slowly, which fits that reasoning. The endpoint is appearance rate, a marker, not a downstream outcome.
Nothing specific on file for Proteolytic Enzymes (Proteases). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 4 we read for Proteolytic Enzymes (Proteases). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.